[May 23, 2012] Lowest Price to Sales Ratio in the Pharmaceuticals Industry Detected in Shares of Skystar Bio-Pharmaceutical (SKBI, HSP, ENDP, CRTX, MYL) Tweet May 23, 2012 (SmarTrend(R) News Watch via COMTEX) -- Below are the three companies in the Pharmaceuticals industry with the lowest price to sales per share ratios. Often companies with the lowest ratio present the greatest value to investors.Skystar Bio-Pharmaceutical ranks lowest with a a price to sales ratio of 0.32. Following is Hospira with a a price to sales ratio of 1.34. Endo Pharmaceuticals ranks third lowest with a a price to sales ratio of 1.37. Cornerstone Therapeutics follows with a a price to sales ratio of 1.41, and Mylan rounds out the bottom five with a a price to sales ratio of 1.45. SmarTrend recommended that its subscribers protect gains by selling shares of Mylan on April 9th, 2012 by issuing a Downtrend alert when the shares were trading at $22.11. Since that call, shares of Mylan have fallen 3.8%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup [ Back To TMCnet.com's Homepage ]